Literature DB >> 28738115

Inconsistent Guideline Recommendations for Cardiovascular Prevention and the Debate About Zeroing in on and Zeroing LDL-C Levels With PCSK9 Inhibitors.

John P A Ioannidis1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28738115     DOI: 10.1001/jama.2017.6765

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Update on task force terminology and outreach activities: Advancing guideline usability for the Canadian primary care context.

Authors:  Brett D Thombs; Sharon E Straus; Ainsley E Moore
Journal:  Can Fam Physician       Date:  2019-01       Impact factor: 3.275

2. 

Authors:  Brett D Thombs; Sharon E Straus; Ainsley E Moore
Journal:  Can Fam Physician       Date:  2019-01       Impact factor: 3.275

Review 3.  Lipid Screening, Action, and Follow-up in Children and Adolescents.

Authors:  Albert Wiegman
Journal:  Curr Cardiol Rep       Date:  2018-08-09       Impact factor: 2.931

Review 4.  CVD Risk Stratification in the PCSK9 Era: Is There a Role for LDL Subfractions?

Authors:  Christian Abendstein Kjellmo; Anders Hovland; Knut Tore Lappegård
Journal:  Diseases       Date:  2018-05-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.